What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded ...

Shares of Illumina Inc. ILMN shed 1.51% to $100.24 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Shares of genomics company Illumina (NASDAQ ... would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock dropped 6.3% on ...

That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...

Illumina has struggled to boost sales and consistently ... the uncertainty it introduced this week left the stock ripe for a fall when its earnings report left investors unimpressed.

Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday. The company posted quarterly ...

Chicago Partners Investment Group LLC acquired a new stake in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) in the 4th quarter, according to the company in its most recent filing with the ...

Shares of genomics company Illumina (NASDAQ ... would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock dropped 8.6% on ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...